61 – 70 of 996
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
ATOR-1017 (evunzekibart), an Fc-gamma receptor conditional 4-1BB agonist designed for optimal safety and efficacy, activates exhausted T cells in combination with anti-PD-1
(
- Contribution to journal › Article
-
Mark
Design, structure and plasma binding of ancestral β-CoV scaffold antigens
(
- Contribution to journal › Article
-
Mark
Protein Biomarker Signatures in Precision Diagnostics of Cancer
2023) p.487-505(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Selection, characterization and in vivo evaluation of novel CD44v6-targeting antibodies for targeted molecular radiotherapy
(
- Contribution to journal › Article
-
Mark
Early Pharmacodynamic Changes Measured Using RNA Sequencing of Peripheral Blood from Patients in a Phase I Study with Mitazalimab, a Potent CD40 Agonistic Monoclonal Antibody
(
- Contribution to journal › Article
-
Mark
Regulators of proteostasis are translationally repressed in fibroblasts from patients with sporadic and LRRK2-G2019S Parkinson’s disease
(
- Contribution to journal › Article
-
Mark
The Bispecific Tumor Antigen-Conditional 4-1BB x 5T4 Agonist, ALG.APV-527, Mediates Strong T-Cell Activation and Potent Antitumor Activity in Preclinical Studies
(
- Contribution to journal › Article
-
Mark
Upper airway microbiome transplantation for patients with chronic rhinosinusitis
(
- Contribution to journal › Article
-
Mark
Single-cell analysis of myeloid cells in HPV+ tonsillar cancer
(
- Contribution to journal › Article
-
Mark
Is lung involvement a favorable prognostic factor for pancreatic ductal adenocarcinoma with synchronous liver metastases?—A propensity score analysis
2023) In Expert Review of Gastroenterology and Hepatology(
- Contribution to journal › Article